Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07025915
PHASE1
A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
View on ClinicalTrials.gov
Summary
This study aims to evaluate the absorption, metabolism, and excretion of a single oral dose of \[¹⁴C\]SSS17 in healthy adult Chinese male subjects, elucidating its overall pharmacokinetic profile in humans to provide essential information for its rational clinical use.
Official title: A Mass Balance Study of [14C]SSS17 in Healthy Chinese Male Subjects
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2025-06
Completion Date
2025-07
Last Updated
2025-06-25
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
[14C]SSS17
single oral dose